Siliciano RF - Search Results

1

Multi-step inhibition explains HIV-1 protease inhibitor pharmacodynamics and resistance.

Rabi SA, Laird GM, Durand CM, Laskey S, Shan L, Bailey JR, Chioma S, Moore RD, Siliciano RF. Rabi SA, et al. Among authors: siliciano rf. J Clin Invest. 2013 Sep;123(9):3848-60. doi: 10.1172/JCI67399. Epub 2013 Aug 27. J Clin Invest. 2013. PMID: 23979165 Free PMC article.

2

The role of CD4 in HIV envelope-mediated pathogenesis.

Siliciano RF. Siliciano RF. Curr Top Microbiol Immunol. 1996;205:159-79. doi: 10.1007/978-3-642-79798-9_8. Curr Top Microbiol Immunol. 1996. PMID: 8575195 Review.

3

A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.

Persaud D, Pierson T, Ruff C, Finzi D, Chadwick KR, Margolick JB, Ruff A, Hutton N, Ray S, Siliciano RF. Persaud D, et al. Among authors: siliciano rf. J Clin Invest. 2000 Apr;105(7):995-1003. doi: 10.1172/JCI9006. J Clin Invest. 2000. PMID: 10749578 Free PMC article.

4

Latency and viral persistence in HIV-1 infection.

Siliciano JD, Siliciano RF. Siliciano JD, et al. Among authors: siliciano rf. J Clin Invest. 2000 Oct;106(7):823-5. doi: 10.1172/JCI11246. J Clin Invest. 2000. PMID: 11018068 Free PMC article. No abstract available.

5

Establishment of latent HIV-1 infection of resting CD4(+) T lymphocytes does not require inactivation of Vpr.

Shen A, Siliciano JD, Pierson TC, Buck CB, Siliciano RF. Shen A, et al. Among authors: siliciano jd, siliciano rf. Virology. 2000 Dec 5;278(1):227-33. doi: 10.1006/viro.2000.0650. Virology. 2000. PMID: 11112497 Free article.

6

MHC class II genotype and the control of viremia in HIV-1-infected individuals on highly active antiretroviral therapy.

Blankson JN, Siliciano RF. Blankson JN, et al. Among authors: siliciano rf. J Clin Invest. 2001 Mar;107(5):549-51. doi: 10.1172/JCI12430. J Clin Invest. 2001. PMID: 11238554 Free PMC article. No abstract available.

7

HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.

Hermankova M, Ray SC, Ruff C, Powell-Davis M, Ingersoll R, D'Aquila RT, Quinn TC, Siliciano JD, Siliciano RF, Persaud D. Hermankova M, et al. Among authors: siliciano jd, siliciano rf. JAMA. 2001 Jul 11;286(2):196-207. doi: 10.1001/jama.286.2.196. JAMA. 2001. PMID: 11448283

8

The challenge of viral reservoirs in HIV-1 infection.

Blankson JN, Persaud D, Siliciano RF. Blankson JN, et al. Among authors: siliciano rf. Annu Rev Med. 2002;53:557-93. doi: 10.1146/annurev.med.53.082901.104024. Annu Rev Med. 2002. PMID: 11818490 Review.

9

Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads.

Kieffer TL, Finucane MM, Nettles RE, Quinn TC, Broman KW, Ray SC, Persaud D, Siliciano RF. Kieffer TL, et al. Among authors: siliciano rf. J Infect Dis. 2004 Apr 15;189(8):1452-65. doi: 10.1086/382488. Epub 2004 Apr 5. J Infect Dis. 2004. PMID: 15073683

10

Mechanisms of HIV-1 escape from immune responses and antiretroviral drugs.

Bailey J, Blankson JN, Wind-Rotolo M, Siliciano RF. Bailey J, et al. Among authors: siliciano rf. Curr Opin Immunol. 2004 Aug;16(4):470-6. doi: 10.1016/j.coi.2004.05.005. Curr Opin Immunol. 2004. PMID: 15245741 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

356 results

Search Page

Filters